DBV Technologies (DBVT) Free Cash Flow Growth (1y) (2021 - 2026)
DBV Technologies (DBVT) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | 7.12% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn | 1,092.51% |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 66.37% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 3.98% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 137.65% |
| 10 | DBV Technologies | 5.96 Bn | 5.79 Bn | - | -56.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -56.34% |
| Mar 31, 2026 | -151.27% |
| Dec 31, 2025 | -193.11% |
| Sep 30, 2025 | -42.51% |
| Jun 30, 2025 | 5.32% |
| Mar 31, 2025 | 45.32% |
| Dec 31, 2024 | 13.61% |
| Sep 30, 2024 | -16.46% |
| Jun 30, 2024 | -39.23% |
| Mar 31, 2024 | -71.95% |
| Dec 31, 2023 | 41.26% |
| Sep 30, 2023 | 3.91% |
| Jun 30, 2023 | -145.20% |
| Mar 31, 2023 | -1,198.14% |
| Dec 31, 2022 | -21.30% |
| Sep 30, 2022 | 10.97% |
| Jun 30, 2022 | 65.19% |
| Mar 31, 2022 | 95.56% |
| Dec 31, 2021 | 41.25% |
| Sep 30, 2021 | 45.69% |